Aditya Birla Sun Life Pharma and Healthcare Fund
Direct · Growth ₹40.60
04 Aug 2026
NAV
19.5%
3Y CAGR
20.2%
5Y CAGR
20.9%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
2.85
Sharpe
-20.5%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹13.11 L | 23.9% | -27.8% | 86.2% |
| 3 Years | ₹36.00 L | ₹46.06 L | 18.5% | -0.2% | 38.4% |
| 5 Years | ₹60.00 L | ₹95.42 L | 20.4% | 13.8% | 28.9% |
| 7 Years | ₹84.00 L | ₹1.66 Cr | 19.4% | 18.2% | 20.4% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 23.9% | 14.5% | 13.9% | +9.4% |
| 3 Years | 18.5% | 11.2% | 16.8% | +7.3% |
| 5 Years | 20.4% | 10.4% | 16.9% | +9.9% |
| 7 Years | 19.4% | 10.6% | 16.6% | +8.8% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 23.2% | 18.1% | -15.6% | 72.9% | 0.72 | 2.59 | 80% | — | — |
| 3 Years | 19.5% | 19.7% | 12.1% | 27.8% | 3.47 | — | 100% | — | — |
| 5 Years | 20.2% | 20.6% | 13.7% | 29.3% | 2.85 | — | 100% | — | — |
-20.5%
Max Drawdown
9 mo
Drawdown Duration
13 mo
Recovery Time
-5.2%
Avg Drawdown
Calmar Ratio by Duration
1.14
1Y
0.95
3Y
0.99
5Y
1.06
7Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +15.17 | 0.53 | 66.0% | 43.8% | 18.3% | 0.2% |
| 3 Years | +14.91 | 0.54 | 69.0% | 46.5% | 22.5% | 8.5% |
| 5 Years | +6.90 | 0.54 | 60.7% | 48.8% | 14.7% | 9.0% |
| 7 Years | +12.54 | 0.50 | 58.3% | 42.5% | 22.1% | 12.5% |
| 10 Years | +7.66 | 0.50 | 58.5% | 42.4% | 14.9% | 7.9% |
| 12 Years | +5.72 | 0.50 | 58.5% | 42.4% | 12.3% | 6.6% |
| 15 Years | +3.83 | 0.50 | 58.5% | 42.4% | 9.7% | 5.2% |
36
Total Holdings
52.1%
Top 10 Weight
4
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 12.09% |
| 2 | Apollo Hospitals Enterprise Limited | 7.30% |
| 3 | J.B. Chemicals & Pharmaceuticals Limited | 4.71% |
| 4 | Torrent Pharmaceuticals Limited | 4.68% |
| 5 | Aurobindo Pharma Limited | 4.55% |
| 6 | Ajanta Pharmaceuticals Limited | 4.38% |
| 7 | Mankind Pharma Ltd | 3.92% |
| 8 | Lupin Limited | 3.74% |
| 9 | SAI Life Sciences Ltd | 3.50% |
| 10 | Abbott India Limited | 3.26% |